Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Megakaryocytes | 21 | 2004 | 26 | 1.760 |
Why?
|
| Blood Platelets | 11 | 2004 | 49 | 0.990 |
Why?
|
| Bone Marrow Cells | 8 | 2005 | 57 | 0.460 |
Why?
|
| Osteogenesis | 3 | 2009 | 99 | 0.410 |
Why?
|
| Animals | 31 | 2009 | 4577 | 0.380 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2009 | 46 | 0.360 |
Why?
|
| Ultrasonic Therapy | 1 | 2009 | 20 | 0.350 |
Why?
|
| Guinea Pigs | 15 | 2004 | 63 | 0.350 |
Why?
|
| Stromal Cells | 2 | 2005 | 35 | 0.310 |
Why?
|
| Cell Culture Techniques | 2 | 2004 | 44 | 0.310 |
Why?
|
| Cell Differentiation | 5 | 2004 | 146 | 0.300 |
Why?
|
| Rats | 10 | 2009 | 858 | 0.280 |
Why?
|
| Cells, Cultured | 12 | 2005 | 676 | 0.260 |
Why?
|
| Thrombopoietin | 3 | 1997 | 4 | 0.250 |
Why?
|
| Titanium | 2 | 2005 | 211 | 0.250 |
Why?
|
| Interleukin-6 | 2 | 1997 | 108 | 0.240 |
Why?
|
| Immunomagnetic Separation | 1 | 2004 | 4 | 0.240 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 153 | 0.240 |
Why?
|
| Recombinant Proteins | 7 | 2009 | 251 | 0.200 |
Why?
|
| Cytoskeleton | 5 | 1990 | 51 | 0.200 |
Why?
|
| Thrombocytopenia | 3 | 1991 | 30 | 0.180 |
Why?
|
| Bone Regeneration | 3 | 2005 | 73 | 0.170 |
Why?
|
| Nerve Regeneration | 2 | 2009 | 14 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 3 | 2005 | 123 | 0.170 |
Why?
|
| Blood Proteins | 2 | 1997 | 20 | 0.160 |
Why?
|
| Integrins | 2 | 1995 | 19 | 0.160 |
Why?
|
| Stem Cells | 2 | 1995 | 46 | 0.160 |
Why?
|
| Receptors, Cytoadhesin | 2 | 1995 | 2 | 0.150 |
Why?
|
| Microtubules | 4 | 1990 | 26 | 0.140 |
Why?
|
| Extracellular Matrix | 2 | 1992 | 74 | 0.130 |
Why?
|
| Ultrasonics | 2 | 2005 | 15 | 0.130 |
Why?
|
| Adenosine Diphosphate | 3 | 1986 | 6 | 0.130 |
Why?
|
| Glycoproteins | 3 | 1992 | 58 | 0.120 |
Why?
|
| Ploidies | 2 | 1991 | 6 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2008 | 453 | 0.120 |
Why?
|
| Models, Animal | 3 | 2009 | 126 | 0.120 |
Why?
|
| Male | 12 | 2009 | 15637 | 0.110 |
Why?
|
| Bone Density | 2 | 2009 | 144 | 0.100 |
Why?
|
| Microbial Collagenase | 1 | 1990 | 11 | 0.090 |
Why?
|
| Fibrinogen | 2 | 1992 | 19 | 0.090 |
Why?
|
| Rats, Inbred WF | 2 | 1991 | 6 | 0.090 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 34 | 0.090 |
Why?
|
| Rats, Long-Evans | 1 | 2009 | 13 | 0.090 |
Why?
|
| Sodium | 3 | 1986 | 76 | 0.090 |
Why?
|
| Ossification, Heterotopic | 1 | 2009 | 42 | 0.090 |
Why?
|
| Guided Tissue Regeneration | 1 | 2009 | 10 | 0.090 |
Why?
|
| X-Ray Microtomography | 1 | 2009 | 78 | 0.090 |
Why?
|
| Axons | 1 | 2009 | 37 | 0.090 |
Why?
|
| G(M1) Ganglioside | 1 | 2008 | 2 | 0.080 |
Why?
|
| Rodent Diseases | 1 | 1988 | 1 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 65 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 364 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 437 | 0.080 |
Why?
|
| Radiculopathy | 1 | 2008 | 62 | 0.080 |
Why?
|
| Thrombin | 3 | 1993 | 12 | 0.080 |
Why?
|
| Actinin | 2 | 1984 | 7 | 0.080 |
Why?
|
| Cell Division | 2 | 1997 | 114 | 0.070 |
Why?
|
| Osteogenesis, Distraction | 1 | 2005 | 12 | 0.070 |
Why?
|
| Mandible | 1 | 2005 | 15 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1992 | 78 | 0.070 |
Why?
|
| Implants, Experimental | 1 | 2005 | 31 | 0.070 |
Why?
|
| Osteoblasts | 1 | 2005 | 63 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 58 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 86 | 0.060 |
Why?
|
| Cell Separation | 3 | 1991 | 42 | 0.060 |
Why?
|
| Receptors, Vitronectin | 2 | 1995 | 5 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2005 | 102 | 0.060 |
Why?
|
| Surface Properties | 1 | 2004 | 144 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 1984 | 30 | 0.060 |
Why?
|
| Collagen | 4 | 2009 | 102 | 0.060 |
Why?
|
| Gene Expression | 1 | 2005 | 226 | 0.060 |
Why?
|
| Alloys | 1 | 2004 | 102 | 0.060 |
Why?
|
| Materials Testing | 1 | 2004 | 137 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 2004 | 114 | 0.060 |
Why?
|
| Microscopy, Electron | 3 | 1990 | 70 | 0.060 |
Why?
|
| Ionophores | 1 | 1983 | 2 | 0.060 |
Why?
|
| Hematopoiesis | 2 | 1997 | 11 | 0.060 |
Why?
|
| In Vitro Techniques | 3 | 1990 | 213 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 1982 | 22 | 0.050 |
Why?
|
| Cell Movement | 3 | 1987 | 105 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 1992 | 260 | 0.050 |
Why?
|
| Bone Development | 1 | 2001 | 35 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2001 | 167 | 0.040 |
Why?
|
| Molecular Weight | 2 | 1990 | 45 | 0.040 |
Why?
|
| Interleukin-11 | 1 | 1997 | 4 | 0.040 |
Why?
|
| Marine Toxins | 1 | 1997 | 2 | 0.040 |
Why?
|
| Interleukin-3 | 1 | 1997 | 2 | 0.040 |
Why?
|
| Thymidine | 1 | 1997 | 7 | 0.040 |
Why?
|
| Genistein | 1 | 1997 | 3 | 0.040 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1997 | 5 | 0.040 |
Why?
|
| Okadaic Acid | 1 | 1997 | 4 | 0.040 |
Why?
|
| Oxazoles | 1 | 1997 | 3 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1997 | 21 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1997 | 10 | 0.040 |
Why?
|
| Phosphates | 1 | 1997 | 21 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 1997 | 78 | 0.040 |
Why?
|
| Phosphorylation | 1 | 1997 | 159 | 0.040 |
Why?
|
| Kinetics | 1 | 1997 | 225 | 0.040 |
Why?
|
| Mice | 3 | 2009 | 1620 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 145 | 0.040 |
Why?
|
| Actins | 2 | 1990 | 45 | 0.040 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 1995 | 8 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1995 | 35 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1995 | 44 | 0.030 |
Why?
|
| Antibodies | 1 | 1995 | 65 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 1984 | 43 | 0.030 |
Why?
|
| Amiloride | 2 | 1983 | 5 | 0.030 |
Why?
|
| Laminin | 2 | 2009 | 8 | 0.030 |
Why?
|
| Prothrombin | 1 | 1993 | 4 | 0.030 |
Why?
|
| Drug Combinations | 2 | 2009 | 83 | 0.030 |
Why?
|
| Vitronectin | 1 | 1992 | 1 | 0.030 |
Why?
|
| Dogs | 2 | 2005 | 253 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 1993 | 51 | 0.030 |
Why?
|
| Culture Media | 1 | 1992 | 38 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1992 | 30 | 0.030 |
Why?
|
| Blood | 1 | 1992 | 25 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 193 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 246 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1992 | 99 | 0.030 |
Why?
|
| Membrane Fluidity | 1 | 1991 | 6 | 0.030 |
Why?
|
| Membrane Lipids | 1 | 1991 | 16 | 0.030 |
Why?
|
| Proteoglycans | 2 | 2009 | 337 | 0.030 |
Why?
|
| Magnetics | 1 | 1991 | 3 | 0.020 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1991 | 6 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1991 | 36 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2005 | 770 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2005 | 323 | 0.020 |
Why?
|
| Nocodazole | 1 | 1990 | 1 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 1990 | 6 | 0.020 |
Why?
|
| Alkaloids | 1 | 1990 | 5 | 0.020 |
Why?
|
| Paclitaxel | 1 | 1990 | 74 | 0.020 |
Why?
|
| Cell Survival | 2 | 1988 | 169 | 0.020 |
Why?
|
| Rabbits | 2 | 1988 | 283 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2009 | 11 | 0.020 |
Why?
|
| Centrifugation | 1 | 1989 | 4 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2009 | 48 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2009 | 22 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 125 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2009 | 36 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 1988 | 29 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 130 | 0.020 |
Why?
|
| Cytochalasins | 1 | 1987 | 1 | 0.020 |
Why?
|
| Vincristine | 1 | 1987 | 26 | 0.020 |
Why?
|
| Colchicine | 1 | 1987 | 10 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2008 | 290 | 0.020 |
Why?
|
| Microradiography | 1 | 2005 | 4 | 0.020 |
Why?
|
| Mandibular Nerve | 1 | 2005 | 4 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2005 | 20 | 0.020 |
Why?
|
| Shear Strength | 1 | 2005 | 7 | 0.020 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2005 | 14 | 0.020 |
Why?
|
| Hydroxyapatites | 1 | 2005 | 9 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2005 | 38 | 0.020 |
Why?
|
| Genes, jun | 1 | 2005 | 3 | 0.020 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2005 | 4 | 0.020 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 6 | 0.020 |
Why?
|
| Osteonectin | 1 | 2005 | 6 | 0.020 |
Why?
|
| Osteopontin | 1 | 2005 | 4 | 0.020 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 8 | 0.020 |
Why?
|
| Genes, myc | 1 | 2005 | 6 | 0.020 |
Why?
|
| Growth Substances | 1 | 2005 | 41 | 0.020 |
Why?
|
| Calcium Phosphates | 1 | 2005 | 25 | 0.020 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 25 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 30 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 726 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2005 | 29 | 0.020 |
Why?
|
| Chemical Precipitation | 1 | 1985 | 1 | 0.020 |
Why?
|
| Immunoelectrophoresis | 1 | 1985 | 4 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1985 | 9 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 38 | 0.020 |
Why?
|
| Internal Fixators | 1 | 2005 | 54 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2005 | 62 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2005 | 166 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 145 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2005 | 125 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2008 | 349 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2005 | 157 | 0.020 |
Why?
|
| Monensin | 1 | 1983 | 1 | 0.010 |
Why?
|
| Nigericin | 1 | 1983 | 1 | 0.010 |
Why?
|
| Cations, Monovalent | 1 | 1983 | 11 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 1983 | 7 | 0.010 |
Why?
|
| Calcimycin | 1 | 1983 | 4 | 0.010 |
Why?
|
| Serotonin | 1 | 1983 | 40 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 255 | 0.010 |
Why?
|
| Potassium | 1 | 1983 | 67 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1983 | 148 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1983 | 189 | 0.010 |
Why?
|
| Filamins | 1 | 1982 | 3 | 0.010 |
Why?
|
| Arachidonic Acids | 1 | 1982 | 5 | 0.010 |
Why?
|
| Myosins | 1 | 1982 | 7 | 0.010 |
Why?
|
| Contractile Proteins | 1 | 1982 | 6 | 0.010 |
Why?
|
| Tubulin | 1 | 1982 | 16 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1982 | 13 | 0.010 |
Why?
|
| Femur | 1 | 2005 | 398 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 1618 | 0.010 |
Why?
|
| Humerus | 1 | 2001 | 98 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 2001 | 669 | 0.010 |
Why?
|
| Receptors, Interleukin-11 | 1 | 1997 | 1 | 0.010 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 1997 | 1 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 1997 | 5 | 0.010 |
Why?
|
| Esterases | 1 | 1993 | 1 | 0.010 |
Why?
|
| Chymotrypsin | 1 | 1993 | 3 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1993 | 7 | 0.010 |
Why?
|
| Heparitin Sulfate | 1 | 1993 | 5 | 0.010 |
Why?
|
| Trypsin | 1 | 1993 | 6 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1993 | 15 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1993 | 67 | 0.010 |
Why?
|
| Fluorescence Polarization | 1 | 1991 | 1 | 0.010 |
Why?
|
| Phospholipids | 1 | 1991 | 7 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1991 | 38 | 0.010 |
Why?
|
| Cell Count | 1 | 1989 | 99 | 0.010 |
Why?
|
| Cholesterol, Dietary | 1 | 1988 | 2 | 0.010 |
Why?
|
| Thrombocytosis | 1 | 1988 | 3 | 0.010 |
Why?
|
| Platelet Transfusion | 1 | 1988 | 6 | 0.010 |
Why?
|
| Platelet Count | 1 | 1988 | 20 | 0.010 |
Why?
|
| Humans | 2 | 1997 | 29361 | 0.010 |
Why?
|
| Cholesterol | 1 | 1988 | 49 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1988 | 64 | 0.010 |
Why?
|